Search Results - "DI Veroli, Ambra"
-
1
Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia in the ATRA and ATO era
Published in Haematologica (Roma) (01-11-2012)“…The role of allogeneic stem cell transplant in advanced acute promyelocytic leukemia patients who received standard first- and second-line therapy is still…”
Get full text
Journal Article -
2
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX‐IOL study
Published in British journal of haematology (01-04-2022)“…Summary Deferasirox (DFX) is used for the management of iron overload (IOL) in many haematological malignancies including myelofibrosis (MF). The ‘RUX‐IOL’…”
Get full text
Journal Article -
3
Second cancers in MPN: Survival analysis from an international study
Published in American journal of hematology (01-03-2020)“…One out of ten patients with Philadelphia‐negative myeloproliferative neoplasms (MPN) develop a second cancer (SC): in such patients we aimed at assessing the…”
Get full text
Journal Article -
4
Treatment in patients with acute myeloid leukemia/high‐risk myelodysplastic syndrome with hypomethylating agents: Day‐hospital management compared to home care setting
Published in European journal of haematology (01-08-2023)“…Objectives Aim of the study was to evaluate the role of a Domiciliary Hematologic Care Unit (DHCU) compared to standard DH setting in the active frontline…”
Get full text
Journal Article -
5
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study
Published in Blood (30-01-2020)“…Patients with Philadelphia-negative myeloproliferative neoplasm (MPN) are prone to the development of second cancers, but the factors associated with these…”
Get full text
Journal Article -
6
-
7
Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group
Published in Annals of hematology (01-06-2022)“…Ruxolitinib is approved for polycythemia vera (PV) patients after failure to previous cytoreductive therapy, based on durable results observed in phase 3…”
Get full text
Journal Article -
8
Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience
Published in Cancers (01-10-2022)“…Elderly patients represent the most challenging and hard-to-treat patient population due to dismal characteristics of the disease, such as secondary-acute…”
Get full text
Journal Article -
9
Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations
Published in British journal of haematology (01-08-2019)Get full text
Journal Article -
10
Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes
Published in Cancers (16-09-2019)“…Myelodysplastic syndromes (MDS) are highly heterogeneous myeloid diseases, characterized by frequent genetic/chromosomal aberrations. Olaparib is a potent,…”
Get full text
Journal Article -
11
Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients
Published in PloS one (15-05-2017)“…P. jiroveci (Pj) causes a potentially fatal pneumonia in immunocompromised patients and the factors associated with a bad outcome are poorly understood. A…”
Get full text
Journal Article -
12
Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the “Ph1‐negative Myeloproliferative Neoplasms Latium Group”
Published in European journal of haematology (01-09-2020)“…Background and aims Anagrelide is a drug effective in reducing platelet counts in essential thrombocythemia (ET) and Ph1‐negative myeloproliferative neoplasms…”
Get full text
Journal Article -
13
Bosutinib in the real‐life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine‐kinase inhibitors
Published in Hematological oncology (01-08-2021)“…To evaluate the role of bosutinib in elderly patients aged >65 years with chronic myeloid leukemia (CML), a real‐life cohort of 101 chronic‐phase CML patients…”
Get full text
Journal Article -
14
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide
Published in Blood cancer journal (New York) (07-09-2022)Get full text
Journal Article -
15
Treatment of Philadelphia‐negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors
Published in Hematological oncology (01-08-2019)“…There have been some reports on a possible role of azacytidine (AZA) in the treatment of accelerated/blastic phase evolved from Philadelphia‐negative…”
Get full text
Journal Article -
16
Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia
Published in Thrombosis research (01-11-2013)“…Abstract Introduction Central venous catheters (CVC) related thrombosis (CRT) represents a well known complication in patients with acute myeloid leukemia…”
Get full text
Journal Article -
17
Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patients
Published in American journal of hematology (01-03-2016)“…Spleen enlargement, present in 10–20% of Essential Thrombocythemia (ET) patients at diagnosis, is a feature clinically easy to assess, confirmable by…”
Get full text
Journal Article -
18
Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical-Biological Entity?
Published in Journal of clinical medicine (05-05-2022)“…Aims: To define the peculiar features of patients with the deletion of the chromosome 20 long arm (del20q), data from 69 patients with myelodysplastic…”
Get full text
Journal Article -
19
Prognostic factors and treatment of secondary leukemia
Published in HemaSphere (01-06-2018)Get full text
Journal Article -
20
Central nervous system involvement in adult acute lymphoblastic leukemia: diagnostic tools, prophylaxis, and therapy
Published in Mediterranean journal of hematology and infectious diseases (01-01-2014)“…In adult patients with acute lymphoblastic leukemia (ALL), Central Nervous System (CNS) involvement is associated with a very poor prognosis. The diagnostic…”
Get full text
Journal Article